Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II–IIIc breast cancer
Titel:
Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II–IIIc breast cancer
Auteur:
Montero, A. J. Diaz-Montero, C. M. Deutsch, Y. E. Hurley, J. Koniaris, L. G. Rumboldt, T. Yasir, S. Jorda, M. Garret-Mayer, E. Avisar, E. Slingerland, J. Silva, O. Welsh, C. Schuhwerk, K. Seo, P. Pegram, M. D. Glück, S.